MHC class I-restricted CTL responses to exogenous antigens.

[1]  C. Leclerc,et al.  Induction of cytotoxic T‐cell response by optimal‐length peptides does not require CD4+ T‐cell help , 1996, Immunology.

[2]  A. Lanzavecchia,et al.  Mechanisms of antigen uptake for presentation. , 1996, Current opinion in immunology.

[3]  S. Buus,et al.  pH dependence of MHC class I-restricted peptide presentation. , 1996, Journal of immunology.

[4]  J. Kihlberg,et al.  Immunization with glycosylated Kb‐binding peptides generates carbohydrate‐specific, unrestricted cytotoxic T cells , 1996, European journal of immunology.

[5]  D. Pardoll,et al.  In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. , 1996, Immunity.

[6]  K. Rock.  A new foreign policy: MHC class I molecules monitor the outside world. , 1996, Immunology today.

[7]  C. Melief,et al.  B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.

[8]  D. Pardoll,et al.  Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo? , 1996, The Journal of experimental medicine.

[9]  M. Petri,et al.  Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Ljunggren,et al.  TAP1‐deficient mice select a CD8+ T cell repertoire that displays both diversity and peptide specificity , 1996, European journal of immunology.

[11]  A. Aderem,et al.  Mechanisms of phagocytosis. , 1996, Current opinion in immunology.

[12]  A. Pearson.  Scavenger receptors in innate immunity. , 1996, Current opinion in immunology.

[13]  J. Kihlberg,et al.  Major histocompatibility complex class I binding glycopeptides for the estimation of 'empty' class I molecules. , 1995, Journal of immunological methods.

[14]  N. Shastri,et al.  Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. , 1995, Immunity.

[15]  J. Reimann,et al.  Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation. , 1995, Journal of immunology.

[16]  Y. Barenholz,et al.  Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. , 1995, Journal of immunology.

[17]  R. Germain,et al.  Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis , 1995, The Journal of experimental medicine.

[18]  S. Pierce,et al.  The novelty of antigen-processing compartments. , 1995, Journal of immunology.

[19]  R. Steinman,et al.  The endocytic activity of dendritic cells , 1995, The Journal of experimental medicine.

[20]  C Danieli,et al.  Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , 1995, The Journal of experimental medicine.

[21]  E. Lederer,et al.  Characterization of TAP‐Independent and Brefeldin A‐Resistant Presentation of Sendai Virus Antigen to CD8+ Cytotoxic T Lymphocytes , 1995, Scandinavian journal of immunology.

[22]  K. Rock,et al.  Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity , 1995, Nature Medicine.

[23]  S. Tonegawa,et al.  TAP1‐independent loading of class I molecules by exogenous viral proteins , 1995, European journal of immunology.

[24]  S. Tonegawa,et al.  MHC class I expression and CD8+ T cell development in TAP1/beta 2-microglobulin double mutant mice. , 1995, International immunology.

[25]  R. Steinman,et al.  The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing , 1995, Nature.

[26]  M. Jackson,et al.  Phagocyte‐induced antigen‐specific activation of unprimed CD8+ T cells in vitro , 1995, European journal of immunology.

[27]  B. Rouse,et al.  Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. , 1995, International immunology.

[28]  E. Lederer,et al.  Heat-inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses in vivo. , 1995, Journal of immunology.

[29]  P. Robinson,et al.  Glycosylphosphatidylinositol‐linked Db does not induce an influenza‐specific cytotoxic T lymphocyte response or recycle membrane‐bound peptides , 1995, European journal of immunology.

[30]  J. Reimann,et al.  Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I‐restricted epitope presentation , 1995, European journal of immunology.

[31]  L. Norkin.  Virus receptors: implications for pathogenesis and the design of antiviral agents , 1995, Clinical microbiology reviews.

[32]  H. Ploegh,et al.  Peptide influences the folding and intracellular transport of free major histocompatibility complex class I heavy chains , 1995, The Journal of experimental medicine.

[33]  R. Cook,et al.  The class I-b molecule Qa-1 forms heterodimers with H-2Ld and a novel 50-kD glycoprotein encoded centromeric to I-E beta , 1995, The Journal of experimental medicine.

[34]  M. Sugita,et al.  Association of the Invariant Chain with Major Histocompatibility Complex Class I Molecules Directs Trafficking to Endocytic Compartments (*) , 1995, The Journal of Biological Chemistry.

[35]  M. Kovacsovics-Bankowski,et al.  A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules , 1995, Science.

[36]  S. Tonegawa,et al.  Differential reactivity of residual CD8+ T lymphocytes in TAP1 and β2‐microglobulin mutant mice , 1995 .

[37]  R. Wagner,et al.  Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens. , 1995, Vaccine.

[38]  A. Vitiello,et al.  Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. , 1995, The Journal of clinical investigation.

[39]  C. Harding,et al.  Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. , 1994, Journal of immunology.

[40]  P. Romero,et al.  Leishmania major infection in mice primes for specific major histocompatibility complex class I‐restricted CD8+ cytotoxic T cell responses , 1994, European journal of immunology.

[41]  D. Strunk,et al.  Fetal skin-derived MHC class I+, MHC class II- dendritic cells stimulate MHC class I-restricted responses of unprimed CD8+ T cells. , 1994, Journal of immunology.

[42]  K. Steimer,et al.  Induction of HIV‐1 envelope (gp120)‐specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell‐derived gp120 is enhanced by enzymatic removal of N‐linked glycans , 1994, European journal of immunology.

[43]  W. Deppert,et al.  CD8+ T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins. , 1994, Journal of immunology.

[44]  J. Reimann,et al.  Injection of detergent‐denatured ovalbumin primes murine class I‐restricted cytotoxic T cells in vivo , 1994, European journal of immunology.

[45]  J. Ulmer,et al.  Presentation of an exogenous antigen by major histocompatibility complex class I molecules , 1994, European journal of immunology.

[46]  J. Reimann,et al.  Peptide transporter‐independent, stress protein‐mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation , 1994, European journal of immunology.

[47]  S. Kaufmann,et al.  Presentation of Listeria monocytogenes antigens by major histocompatibility complex class I molecules to CD8 cytotoxic T lymphocytes independent of listeriolysin secretion and virulence , 1994, European journal of immunology.

[48]  B. Carreno,et al.  Exogenous peptide ligand influences the expression and half‐life of free HLA class I heavy chains ubiquitously detected at the cell surface , 1994, European journal of immunology.

[49]  P. Srivastava,et al.  Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. , 1994, Journal of immunology.

[50]  E. Jaffee,et al.  Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. , 1994, Science.

[51]  J. Reimann,et al.  Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen , 1994, European journal of immunology.

[52]  P. Srivastava,et al.  Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[53]  C. Kensil,et al.  Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes. , 1994, Cellular immunology.

[54]  M. Edidin,et al.  Clustering of class I HLA molecules on the surfaces of activated and transformed human cells. , 1994, Journal of immunology.

[55]  E. Schneeberger,et al.  Interstitial lung macrophages interact with dendritic cells to present antigenic peptides derived from particulate antigens to T cells. , 1994, Immunology.

[56]  J. Reimann,et al.  Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis , 1994, Journal of virology.

[57]  J. Reimann,et al.  Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo. , 1994, Journal of immunology.

[58]  N. Andrews.  From lysosomes into the cytosol: the intracellular pathway of Trypanosoma cruzi. , 1994, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[59]  M R Jackson,et al.  Regulation of MHC class I transport by the molecular chaperone, calnexin (p88, IP90). , 1994, Science.

[60]  J. Berzofsky,et al.  Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs. , 1994, Journal of immunology.

[61]  A M Haywood,et al.  Virus receptors: binding, adhesion strengthening, and changes in viral structure , 1994, Journal of virology.

[62]  K. Heeg,et al.  Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells. , 1994, Vaccine.

[63]  A. R. Siddiqi,et al.  Major histocompatibility complex class I‐binding peptides are recycled to the cell surface after internalization , 1993, European journal of immunology.

[64]  J. Smith,et al.  Model for the in vivo assembly of nascent Ld class I molecules and for the expression of unfolded Ld molecules at the cell surface , 1993, The Journal of experimental medicine.

[65]  B. Haynes,et al.  Synthetic peptide in mineral oil adjuvant elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes in rhesus monkeys. , 1993, Journal of immunology.

[66]  P. Srivastava,et al.  Heat shock protein 70-associated peptides elicit specific cancer immunity , 1993, The Journal of experimental medicine.

[67]  M. Feltkamp,et al.  Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells , 1993, European journal of immunology.

[68]  C. Sousa,et al.  Phagocytosis of antigens by Langerhans cells in vitro , 1993, The Journal of experimental medicine.

[69]  Z. Li,et al.  Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation. , 1993, The EMBO journal.

[70]  J. Pfeifer,et al.  Processing of defined T-cell epitopes after phagocytosis of intact bacteria by macrophages. , 1993, Infectious agents and disease.

[71]  A. Kingsman,et al.  Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles. , 1993, Journal of immunology.

[72]  B. Nardelli,et al.  Cellular immune responses induced by in vivo priming with a lipid-conjugated multimeric antigen peptide. , 1993, Immunology.

[73]  W. Deppert,et al.  Immunization of mice with the N‐terminal (1–272) fragment of simian virus 40 large T antigen (without adjuvants) specifically primes cytotoxic T lymphocytes , 1993, European journal of immunology.

[74]  M. Hanson,et al.  Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine , 1993, The Journal of experimental medicine.

[75]  K. Rock,et al.  Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[76]  A. Kingsman,et al.  Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion , 1993, Journal of virology.

[77]  N. Letvin,et al.  Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. , 1993, Journal of immunology.

[78]  J. Pfeifer,et al.  Phagocytic processing of bacterial antigens for class I MHC presentation to T cells , 1993, Nature.

[79]  A. Sher,et al.  Bone marrow macrophages process exogenous Toxoplasma gondii polypeptides for recognition by parasite-specific cytolytic T lymphocytes. , 1993, Journal of immunology.

[80]  K. Rock,et al.  Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. , 1993, Journal of immunology.

[81]  J. McCluskey,et al.  Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. Priming in vitro and in vivo for class I-restricted recognition of soluble antigen. , 1993, Journal of immunological methods.

[82]  M. Jackson,et al.  Assembly and intracellular transport of MHC class I molecules. , 1993, Annual review of cell biology.

[83]  P. Srivastava,et al.  Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation. , 1993, Advances in cancer research.

[84]  R. Germain,et al.  The biochemistry and cell biology of antigen processing and presentation. , 1993, Annual review of immunology.

[85]  S. Tonegawa,et al.  TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4−8+ T cells , 1992, Cell.

[86]  J. Dice.  Selective Degradation of Cytosolic Proteins by Lysosomes a , 1992, Annals of the New York Academy of Sciences.

[87]  N. Letvin,et al.  Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes , 1992, The Journal of experimental medicine.

[88]  J. Levy,et al.  Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein. , 1992, Journal of immunology.

[89]  B. Rouse,et al.  Prolonged survival of thymoma-bearing mice after vaccination with a soluble protein antigen entrapped in liposomes: a model study. , 1992, Cancer research.

[90]  A. Kingsman,et al.  Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles. , 1992, Immunology.

[91]  B. Rouse,et al.  Induction of cytotoxic T lymphocytes in vivo with protein antigen entrapped in membranous vehicles. , 1992, Journal of immunology.

[92]  W. Morrow,et al.  Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[93]  L. Berg,et al.  In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides. , 1992, Journal of immunological methods.

[94]  J. Pink,et al.  A recombinant malaria protein that can induce Th1 and CD8+ T cell responses without antibody formation. , 1992, Journal of immunology.

[95]  W. Lie,et al.  Extensive peptide ligand exchange by surface class I major histocompatibility complex molecules independent of exogenous beta 2-microglobulin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[96]  B. Rouse,et al.  Class I restricted CTL recognition of a soluble protein delivered by liposomes containing lipophilic polylysines. , 1992, Journal of immunological methods.

[97]  D. Portnoy,et al.  Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine. , 1992, Journal of immunology.

[98]  A. Osterhaus,et al.  Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition , 1992, The Journal of experimental medicine.

[99]  C. Harding,et al.  Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses. , 1992, Journal of immunology.

[100]  C. Kensil,et al.  Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses. , 1992, Journal of immunology.

[101]  C. Kensil,et al.  Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. , 1992, Journal of immunology.

[102]  B. Rouse,et al.  In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes. , 1992, Journal of immunology.

[103]  W. Deppert,et al.  Immunization with soluble simian virus 40 large T antigen induces a specific response of CD3+ CD4− CD8+ cytotoxic T lymphocytes in mice , 1992, European journal of immunology.

[104]  P. Stahl.  The mannose receptor and other macrophage lectins. , 1992 .

[105]  B. Rouse,et al.  Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro , 1992, The Journal of experimental medicine.

[106]  B. Chain,et al.  Liposome‐mediated delivery stimulates a class I‐restricted cytotoxic T cell response to soluble antigen , 1992, European journal of immunology.

[107]  W. Lie,et al.  Disparate interaction of peptide ligand with nascent versus mature class I major histocompatibility complex molecules: comparisons of peptide binding to alternative forms of Ld in cell lysates and the cell surface , 1992, The Journal of experimental medicine.

[108]  J. Yewdell,et al.  Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. , 1992, Advances in immunology.

[109]  B. Rouse,et al.  Liposomal delivery of soluble protein antigens for class I MHC-mediated antigen presentation. , 1992, Research in immunology.

[110]  H. Rammensee,et al.  Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide , 1991, The Journal of experimental medicine.

[111]  H. Schild,et al.  Efficiency of peptides and lipopeptides for in vivo priming of virus‐specific cytotoxic T cells , 1991, European journal of immunology.

[112]  M. Luscher,et al.  Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis , 1991, Nature.

[113]  R. Young,et al.  Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines , 1991, Nature.

[114]  W. Jacobs,et al.  New use of BCG for recombinant vaccines , 1991, Nature.

[115]  K. Heeg,et al.  Vaccination of class I major histocompatibility complex (MHC)‐restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating‐ovalbumin complexes enter the class I MHC‐restricted antigen pathway and allow sensitization against the immunodominant peptide , 1991, European journal of immunology.

[116]  K. Rock,et al.  Dissociation of β 2-microglobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface , 1991, Cell.

[117]  D. R. Lee,et al.  The specific binding of peptide ligand to Ld class I major histocompatibility complex molecules determines their antigenic structure , 1991, The Journal of experimental medicine.

[118]  J. Berzofsky,et al.  Excess β2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules , 1991, Nature.

[119]  F. Celada,et al.  Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies , 1991, The Journal of experimental medicine.

[120]  F. Brodsky,et al.  The cell biology of antigen processing and presentation. , 1991, Annual review of immunology.

[121]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.

[122]  A. Vitiello,et al.  The role of beta 2-microglobulin in peptide binding by class I molecules. , 1990, Science.

[123]  E. Halapi,et al.  Mycobacterial‐induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients , 1990, European journal of immunology.

[124]  P. Bailly,et al.  Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells , 1990, The Journal of experimental medicine.

[125]  K. Rock,et al.  Reassociation with beta 2-microglobulin is necessary for Kb class I major histocompatibility complex binding of exogenous peptides. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[126]  J. Sadoff,et al.  Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells , 1990, The Journal of experimental medicine.

[127]  C. Watts,et al.  Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments , 1990, Nature.

[128]  Hidde L. Ploegh,et al.  Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro , 1990, Cell.

[129]  Hidde L. Ploegh,et al.  Empty MHC class I molecules come out in the cold , 1990, Nature.

[130]  R. Zinkernagel,et al.  Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide , 1990, The Journal of experimental medicine.

[131]  J. Berzofsky,et al.  Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs , 1990, Nature.

[132]  R. Steinman,et al.  Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells , 1990, The Journal of experimental medicine.

[133]  W. Lie,et al.  Peptide ligand-induced conformation and surface expression of the Ld class I MHC molecule , 1990, Nature.

[134]  L. Isenman,et al.  Secretion of intact proteins and peptide fragments by lysosomal pathways of protein degradation. , 1989, The Journal of biological chemistry.

[135]  H. Rammensee,et al.  In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine , 1989, Nature.

[136]  J. Strominger,et al.  Constitutive endocytosis of HLA class I antigens requires a specific portion of the intracytoplasmic tail that shares structural features with other endocytosed molecules. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[137]  A. Townsend,et al.  Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.

[138]  E. Yunis,et al.  Receptor-like nature of class I HLA: endocytosis via coated pits. , 1988, Journal of immunology.

[139]  H. Karasuyama,et al.  Cytotoxic T lymphocytes against a soluble protein , 1987, Nature.

[140]  D. Wraith,et al.  Purified influenza virus nucleoprotein protects mice from lethal infection. , 1987, The Journal of general virology.

[141]  D. Wraith,et al.  Influenza virus-specific cytotoxic T-cell recognition: stimulation of nucleoprotein-specific clones with intact antigen. , 1986, Immunology.

[142]  R. Flavell,et al.  Beta 2-microglobulin is not required for cell surface expression of the murine class I histocompatibility antigen H-2Db or of a truncated H-2Db. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[143]  F. Ennis,et al.  Influenza virus hemagglutinin-specific cytotoxic T cell response induced by polypeptide produced in Escherichia coli , 1985, The Journal of experimental medicine.

[144]  M. Rijn,et al.  β2-Microglobulin from serum associates with MHC class I antigens on the surface of cultured cells , 1984, Nature.

[145]  U. Koszinowski,et al.  The cytolytic T lymphocyte response to the murine cytomegalovirus. II. Detection of virus replication stage‐specific antigens by separate populations of in vivo active cytolytic T lymphocyte precursors , 1984, European journal of immunology.

[146]  R. Tjian,et al.  Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VI. Mechanism of induction of SV40 transplantation immunity in mice by purified SV40 T antigen (D2 protein). , 1980, Virology.

[147]  D. Solter,et al.  Genetic control of the cytotoxic T cell response to SV40 tumor-associated specific antigen. , 1979, Journal of immunology.

[148]  M. Bevan.  Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay , 1976, The Journal of experimental medicine.